// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Childhood sexual abuse among new psychiatric outpatients in a city in Northern Alberta-prevalence rate and demographic/clinical predictors

V.Agyapong - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cognitive vulnerability to depression in adolescents with depression, their healthy siblings and a control group: A cross-sectional study

G.Chartier - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

The relationship between physical and mental disorders in a pediatric population

G.Chartier - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Supportive text messages for patients with depression – A randomized controlled trial

V.Agyapong - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Mobile health program to reduce psychological treatment gap in mental healthcare in Alberta through daily supportive text messages – Cross-sectional survey evaluating Text4Mood

V.Agyapong - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Online clinic, a new method of delivering psychotherapy

M.Omrani - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

N/A

Intrafamilial homicide: A descriptive study of fratricide in Quebec

D.Bourget - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: A re-analysis of the Quebec pregnancy cohort

A.Brard - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Norepinephrine bitartrate

Peripheral levels of the micro-RNA miR-1202 are correlated with changes in brain activity and connectivity during an antidepressant treatment

J.P.Lopez - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Desvenlafaxine

Classification of first-episode schizophrenia spectrum disorders and controls from whole brain white matter fractional anisotropy using machine learning

P.Mikolas - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Adversity, parental mental illness, and risk of depression in youth

V.Patterson - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Exploring maternal mental health in Syrian refugee women

A.Bowen - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Mental illness and mental health care as experienced by persons who die by suicide; a qualitative analysis of suicide notes

Z.Furqan - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A neuro-developmentally sensitive and trauma informed service delivery approach for child and youth mental health and psychiatry

T.Wilkes - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Outcomes of involuntary hospital admission. Satisfaction with treatment and the effect of involuntary admissions on patients

T.Reshetukha - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Medical assistance in dying: The Canadian experience

K.Gaind - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Beyond the crisis: Ongoing psychiatric treatment and service utilization after initial symptom stabilization following first-episode psychosis for adolescents

R.Gearing - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Description of anesthetic drugs used in hospital del Mar and their impacts on convulsion duration and blood pressure in electroconvulsive therapy

M.Angelats - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Thiopental

Characterizing the inpatient care of young adults experiencing early psychosis

R.Kamieniecki - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effectiveness study of “occupational connections” – A short-term, in-patient intervention for promotion functioning and participation in daily life of people with mental health conditions

L.Lipskaya-Velikovsky - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved